Application Information

Application Number : 2024/014185

Application Date : 31-08-2017

Application Type : EPC Fasikül

Grant Number : 2024-GE-709895

Grant Date : 18-10-2024

Registration Number : 2024 014185

Registration Date : 2024-11-21

Protection Type : Patent

European Patent Publication Number (B1) : EP3506931B1

European Patent Application Number : EP17771619.8

Applicants

Person No	Name	Address
7761384	REGENERON PHARMACEUTICALS INC.	777 OLD SAW MILL RIVER ROAD TARRYTOWN, NY 10591 A.B.D.
7761386	SANOFI BIOTECHNOLOGY	82 AVENUE RASPAIL 94250 GENTILLY FRANSA

Inventors

Person No	Name	Address
7761382	Brian N SWANSON	C/O SANOFI BIOTECHNOLOGY 54 RUE LA BOETIE 75008 PARIS FRANSA
7761381	Jennifer D HAMILTON	C/O REGENERON PHARMACEUTICALS INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.

Invention Information

Name Of Invention	IL-4R ANTAGONİSTİ UYGULAYARAK ALERJİYİ ÖNLEME VEYA TEDAVİ ETME YÖNTEMLERİ
Summary Of Invention	Mevcut buluş, bir denekte alerji tedavisi yönteminde kullanılmak üzere dupilumab ile ilgilidir.

Attorney Information

Name	ZEHRA KÖLÜK DESTEK PATENT A.Ş.
Address	Maslak mah. Saat sk. Spıne tower no:5 Sarıyer/ İSTANBUL

Priority Information

Date of Priority	Priority Number	Country of Priority
01-09-2016	US 201662382501P	US
23-11-2016	US 201662425726P	US

Classes of The Invention

Patent Application Procedures

Date	Date of Notification	Operation
21-10-2024		Yıllık Ücret Ödeme Talebi
	21-10-2024	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
18-10-2024		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
21-11-2024	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)
8	2024	21-10-2024	4810.0